Arno Therapeutics, Inc Fair Value Assumptions, Weighted Average Volatility Rate (Deprecated 2018-01-31)
Arno Therapeutics, Inc reported Fair Value Assumptions, Weighted Average Volatility Rate (Deprecated 2018-01-31) of 162.00% for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-30.
Discontinued › Income Statement › Earnings Per Share
us-gaap:FairValueAssumptionsWeightedAverageVolatilityRate · last filed 2016-03-30
- Arno Therapeutics, Inc fair value assumptions, weighted average volatility rate (deprecated 2018-01-31) for fiscal 2015 was 162.00%, a 6.36% decline from fiscal 2014.
- Arno Therapeutics, Inc fair value assumptions, weighted average volatility rate (deprecated 2018-01-31) for fiscal 2014 was 173.00%, a 60.19% increase from fiscal 2013.
- Arno Therapeutics, Inc fair value assumptions, weighted average volatility rate (deprecated 2018-01-31) for fiscal 2013 was 108.00%.
| Period end | Fair Value Assumptions, Weighted Average Volatility Rate (Deprecated 2018-01-31) 12 month |
|---|---|
| 2015-12-31 | 162.00% 10-K · filed 2016-03-30 |
| 2014-12-31 | 173.00% 10-K · filed 2016-03-30 |
| 2013-12-31 | 108.00% 10-K · filed 2015-03-31 |